Matuzumab is a humanized monoclonal antibody that binds to the epidermal growth factor receptor (EGFR). EGFR existing on the surface of normal and tumor cells binds to EGF (epidermal growth factor) and other EGF family growth factors, which leads to the activation of EGFR. Matuzumab is used as an anti-cancer drug.